bioscrip inc. Resources | BNET
On CBS News: Caffeine Intoxication Cases On Rise

BNET Industries

BioScrip Inc. (BIOS) is in the Retail Industry

Revenue
Dec 31 2007
$1.1B
Profit
Dec 31 2007
$3.3M
Market Cap
Aug 27 2008
$157.0M

Latest News and Analysis

Additional Resources

  • BioScrip to Present at the Noble Financial Equity Conference

    ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) today announced that it will present at the Fourth Annual Noble Financial Equity Conference, to be held August 18-19, 2008, at the Loews Lake Las Vegas Resort, Nevada. BioScrip's Chairman and CEO, Richard H. Friedman, and Stanley G. Rosenbaum, Executive Vice...

    Articles 2008-08-04

  • BeaconEquity.com Issues Technical Trade Alerts on Market Movers: AGIX, APKT, BIOS, NOVA, CNXT, CHRD

    DALLAS, Aug. 1 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting: http://beaconequity.com/m Today's Trade Alerts include: Atherogenics Inc. , Acme Packet Inc. , BioScrip Inc. ,...

    Articles 2008-08-01

  • BioScrip, Inc. Reports 2008 Second Quarter Earnings

    --Revenues of $348.4 Million; EPS of $0.04; Specialty Services Up 25.3%-- ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) today reported net income for the quarter ended June 30, 2008 of $1.6 million, or $0.04 per diluted share, on revenues of $348.4 million, compared to $0.5 million, or $0.01...

    Articles 2008-07-31

  • BioScrip, Inc. Reports First Quarter Revenues of $328 Million - Loss of $0.01; Specialty Services Revenue up 18%

    ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) today reported first quarter 2008 revenues of $327.5 million compared to first quarter 2007 revenues of $296.2 million. First quarter 2008 EBITDAO (earnings before interest, taxes, depreciation, amortization and option expense) was $2.7 million, operating profit was $185,000 and net loss was $0.5...

    Articles 2008-05-02

  • BioScrip to Report First Quarter 2008 Earnings on May 2nd

    ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) announced today that it will host a conference call at 10:00 a.m. ET on May 2, 2008, to discuss its first quarter operating results for the period ended March 31, 2008. BioScrip will issue a press release announcing the operating results before the...

    Articles 2008-05-01

  • BioScrip Holds Annual Meeting; Re-Affirms Focus on Specialty Services

    ELMSFORD, N.Y. -- In remarks at its annual stockholders' meeting, Chairman and Chief Executive Officer, Richard H. Friedman outlined BioScrip's (Nasdaq: BIOS) 2008 key goals and objectives as well as its growth initiatives. At that meeting, Mr. Friedman stated that "By all accounts, BioScrip had a successful year as indicated...

    Articles 2008-04-29

  • Nacel Energy (OTC BB:NCEN) to Supply Wind Energy to Thousands of Americans.

    M2 PRESSWIRE-6 March 2008-WallStreetAnalystReport.com: Nacel Energy (OTC BB:NCEN) to Supply Wind Energy to Thousands of AmericansC1994-2008 M2 COMMUNICATIONS LTD RDATE:06032008 Stocks to Watch: NACEL Energy Corporation (OTC BB:NCEN) , Aspen Exploration Corporation (OTC BB:ASPN), BioScrip Inc (Nasdaq:BIOS) , ...

    Articles 2008-03-06

  • Has added BioScrip Inc. to their watch list.

    M2 PRESSWIRE-5 March 2008-The Maybach Financial Group: Has added BioScrip Inc. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:05032008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants, brokers, researchers,...

    Articles 2008-03-05

  • Fourth Quarter and Year end Results Reported for BioScrip, Inc.

    M2 PRESSWIRE-5 March 2008-investorIM: Fourth Quarter and Year end Results Reported for BioScrip, Inc.C1994-2008 M2 COMMUNICATIONS LTD RDATE:05032008 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world can communicate....

    Articles 2008-03-05

  • BioScrip, Inc. Reports EPS of $0.06 for Fourth Quarter 2007; EPS of $0.09 for 2007; Twelve Months' Operating Income Improves by $25.1 Million

    ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) today reported fourth quarter 2007 net income of $2.5 million, or $0.06 per diluted share, on revenues of $309.2 million. Fourth quarter EBITDAO (earnings before interest, taxes, depreciation, amortization and option expense) was $5.9 million. Full year 2007 net income was $3.3 million...

    Articles 2008-03-04

  • BioScrip to Report Fourth Quarter and Year End 2007 Earnings on March 4th

    ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) announced today that it will host a conference call at 10:00 a.m. ET on March 4, 2008, to discuss its fourth quarter and year end operating results for the period ended December 31, 2007. BioScrip will issue a press release announcing the operating...

    Articles 2008-03-03

  • BioScrip Responds to CAP Inquiries

    ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS), a specialty pharmaceutical healthcare organization, today responded to inquiries regarding CAP Medicare Part B Competitive Acquisition Program 2008 enrollment figures. BioScrip reported that utilizing physicians have increased over the last six months. While CMS has reported an approximately 1,000 physician decrease in CAP...

    Articles 2008-02-07

  • Healthcare News Update.

    M2 PRESSWIRE-5 February 2008-Businessnewsnow.us: Healthcare News UpdateC1994-2008 M2 COMMUNICATIONS LTD RDATE:05022008 New York, NY -- HealthSonix, Inc. (OTC: HSXI); Bio-Imaging Technologies, Inc. (NASDAQ: BITI); Arcadia Resources, Inc. (AMEX: KAD); MedAssets, Inc. (NASDAQ: MDAS); BioScrip, Inc. (NASDAQ: BIOS); Progress ...

    Articles 2008-02-05

  • BioScrip to Present at the UBS Global Healthcare Services Conference

    ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS), a specialty pharmaceutical health care organization, today announced that it will present at the UBS Global Healthcare Services Conference on February 11, 2008 at the Grand Hyatt New York City. BioScrip's Chairman and CEO, Richard Friedman, and Executive Vice President, CFO...

    Articles 2008-02-04

  • BioScrip, Inc. Press Release

    ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS), a comprehensive pharmaceutical care solutions company, today announced that on January 24, 2008, it received written notification from the Nasdaq Listing Qualifications Department ("Nasdaq") that it had violated the shareholder approval requirement set forth in Nasdaq Marketplace Rule 4350i; the notice also indicated...

    Articles 2008-01-25

  • BioScrip, Inc. Announces Opening of Two New Specialty Pharmacies

    ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) today announced the opening of new specialty pharmacies in Hawthorne, New York, and Pompano Beach, Florida. The New York location, situated on the campus of Westchester Medical Center, will offer convenient access to specialty and traditional medications to the more than...

    Articles 2008-01-22

  • BioScrip to Present at 19th Annual Piper Jaffray Health Care Conference

    ELMSFORD, N.Y. -- BioScrip, Inc. (NASDAQ:BIOS), a specialty pharmaceutical health care organization today announced that it will present at the 19th Annual Piper Jaffray Health Care Conference on November 27 at The Pierre Hotel in New York, New York. BioScrip's Chairman and CEO, Richard Friedman,...

    Articles 2007-11-21

  • page 1 of 1
  • Incorporated: 1996
  • CEO: Mr. Richard H. Friedman
  • Employees: 874

BioScrip is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management services. Co.'s specialty pharmaceutical services include the support, dispensing and distribution, patient care management, data reporting and a range of other management services for certain medications. Co.'s pharmacy benefit management services include pharmacy network management, claims processing, benefit design, drug utilization review, formulary management and traditional mail order pharmacy fulfillment.

advertisement
BioScrip Inc. Company Info

Board of Directors

Mr. Richard H. Friedman

Chairman

Mr. Martin Kooper

Ms. Charlotte W. Collins Esquire

Dr. Louis T. DiFazio Ph.D.

Mr. Myron Z. Holubiak

Mr. David R. Hubers

Mr. Richard L. Robbins

Mr. Stuart A. Samuels

Mr. Steven K. Schelhammer

Contact Information

100 Clearbrook Road

Elmsford, NY

http://www.mimcorporation.com

914 460-1600

NAICS Code

Pharmacies and Drug Stores: 44611
advertisement